Series B Investors & VC Firms in Singapore

135 firms in this list, with a median first check of $977.5K. 10 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
Z4 Z47	88🔒	Mumbai	IN	Seed–Series B	$1.2M – $40M	+ Add to CRM
CO Cool Japan Fund KMKK2 people	88🔒	Tokyo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
EP ePlanet Capital AAAJ2 people	88🔒	San Jose	US	Seed–Late Stage	—	+ Add to CRM
DE Delivery Hero Ventures BB1 person	88🔒	Berlin	DE	Seed–Late Stage	—	+ Add to CRM
DG DG Ventures, Inc. KH1 person	88🔒	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
MA Majuven HK1 person	88🔒	—	SG	Seed–Late Stage	—	+ Add to CRM
PA Panthera Growth Partners SK1 person	88🔒	—	SG	Series A–Series B	—	+ Add to CRM
SE Seveno Capital AL1 person	88🔒	—	SG	Pre-Seed–Series B	—	+ Add to CRM
SH Sheares Healthcare Group TU1 person	88🔒	—	SG	Seed–Late Stage	—	+ Add to CRM
V V Ventures MS1 person	88🔒	Lewes	US	Seed–Late Stage	—	+ Add to CRM
BE Believe	88🔒	Singapore	SG	Series B	—	+ Add to CRM
DA Daiwa PI Partners	88🔒	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
EV EvolutionX Debt Capital	88🔒	Singapore	SG	Series A–Growth	—	+ Add to CRM
IN InnoVen Capital	88🔒	Beijing	CN	Series A–Late Stage	—	+ Add to CRM
MA Mars Growth Capital	88🔒	Singapore	SG	Series A–Growth	—	+ Add to CRM

Z47

MumbaiSeed–Series B$1.2M – $40M

Cool Japan Fund

TokyoPre-Seed–Late Stage

KMKK2 people

ePlanet Capital

San JoseSeed–Late Stage

AAAJ2 people

Delivery Hero Ventures

BerlinSeed–Late Stage

BB1 person

DG Ventures, Inc.

TokyoSeed–Late Stage

KH1 person

Majuven

Seed–Late Stage

HK1 person

Panthera Growth Partners

Series A–Series B

SK1 person

Seveno Capital

Pre-Seed–Series B

AL1 person

Sheares Healthcare Group

Seed–Late Stage

TU1 person

V Ventures

LewesSeed–Late Stage

MS1 person

Believe

SingaporeSeries B

Daiwa PI Partners

TokyoSeed–Late Stage

EvolutionX Debt Capital

SingaporeSeries A–Growth

InnoVen Capital

BeijingSeries A–Late Stage

Mars Growth Capital

SingaporeSeries A–Growth

Data sourced from public filings and firms' own websites — see our methodology.